Table of Contents
WASHINGTON — Pfizer executive Paul Sturman has been elected chairman of the board for the Consumer Healthcare Products Association (CHPA).
CHPA said Monday that Sturman, president and general manager of Pfizer Consumer Healthcare, becomes the association’s 54th chairman and succeeds Christopher DeWolf, president and chief executive officer of Lil’ Drug Store Products Inc.
"As our nation seeks cost-effective health care options, CHPA is committed to demonstrating the role, value and accessibility that over-the-counter medicines and dietary supplements provide in our health care delivery system," commented Scott Melville, president and CEO of CHPA. "Paul is a thoughtful and experienced industry leader who brings a keen strategic vision to the association and a commitment to strong board governance and oversight."
Sturman leads Pfizer Consumer Healthcare, one of the world’s largest consumer healthcare businesses. He is responsible for the division’s global operations, including the development and marketing of major OTC health brands such as Advil, Centrum, Caltrate, ChapStick and Robitussin.
"I’m honored to take on this new role and work closely with the board, our allies and Capitol Hill to promote the importance of OTC medicines and dietary supplements in the health care continuum," Sturman said in a statement. "Shaping policies that continue to provide self-care solutions and cost-effective options is a top priority."
Earlier in his career, Sturman has served as president of U.S. and global business development, new products, at Wyeth Consumer Healthcare, and as president for North America, consumer health care, at Johnson & Johnson. He also has held marketing and sales positions of increasing responsibility at the former Pfizer Consumer Healthcare and Warner-Lambert.
